Marcelle Pick examines early signs that semaglutide (Ozempic) might reduce alcohol consumption, but warns the evidence comes from small studies. Larger trials like STAR are underway to determine if it could actually work as an addiction treatment.
The reality is we need more human trials. However, these observations have not yet been confirmed in large controlled clinical trials with human participants, which is really important for validating any medical treatments. So the question is really now, what's next? Certainly further research with the STAR trial. So the encouraging results from this small study have paved the way for larger and more comprehensive studies, such as the semiglutide therapy for alcohol reduction. Now these studies really aim to provide more conclusive evidence on the safety and effectiveness of Ozempic in treating alcohol addiction.
Seeking definite answers the outcomes of these trials are eagerly awaited as they will help really determine whether Ozempic can be officially used as a treatment for alcohol addiction.
